F.S. Correia-Melo, G.C. Leal, M.S. Carvalho, A.P. Jesus-Nunes, C.B. Ferreira, F. Vieira, G. Magnavita, L.A. Vale, R.P. Mello and C. Nakahira, Comparative study of esketamine and racemic ketamine in treatment-resistant depression: Protocol for a non-inferiority clinical trial. Medicine, 97 (2018) e12414.
 J.W. Murrough, C.G. Abdallah and S.J. Mathew, Targeting glutamate signalling in depression: progress and prospects. Nature Reviews Drug Discovery, 16 (2017) 472.
 C. Pittenger, G. Sanacora and J.H. Krystal, The NMDA receptor as a therapeutic target in major depressive disorder. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 6 (2007) 101-115.
 J.W. Murrough, Ketamine for depression: an update. Biological psychiatry, 80 (2016) 416-418.
 C. Andrade, Ketamine for depression, 3: does chirality matter? The Journal of clinical psychiatry, 78 (2017) e674-e677.
 R. Machado-Vieira, G. Salvadore, N. DiazGranados and C.A. Zarate Jr, Ketamine and the next generation of antidepressants with a rapid onset of action. Pharmacology & therapeutics, 123 (2009) 143-150.
 J.B. Singh, M. Fedgchin, E. Daly, L. Xi, C. Melman, G. De Bruecker, A. Tadic, P. Sienaert, F. Wiegand and H. Manji, Intravenous esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled study. Biological psychiatry, 80 (2016) 424-431.
 E.J. Daly, J.B. Singh, M. Fedgchin, K. Cooper, P. Lim, R.C. Shelton, M.E. Thase, A. Winokur, L. Van Nueten and H. Manji, Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial. JAMA psychiatry, 75 (2018) 139-148.
 T.K. Vyas, A. Shahiwala, S. Marathe and A. Misra, Intranasal drug delivery for brain targeting. Current drug delivery, 2 (2005) 165-175.
 D.S. Quintana, N.E. Steen and O.A. Andreassen, The promise of intranasal esketamine as a novel and effective antidepressant. JAMA psychiatry, 75 (2018) 123-124.
 M. Nabati, M.-a. Kermanian, H. Mohammadnejad-Mehrabani, H. Rahbar Kafshboran, M. Mehmannavaz and S. Sarshar, Theoretical Investigation on the Antitumor Drug: ThioTEPA and its Interaction with S-donor Biomolecules and DNA Purine Bases. Chemical Methodologies, 2 (2018) 128-140.
 M. Nabati and M. Mahkam, DFT Study of the Six-Membered Heterocyclic SinN6-nHn (n= 0-6): Stability and Aromaticity. Organic Chemistry Research, 2 (2016) 70-80.
 M. Nabati, Reactivity and aromaticity of hexasiline derivatives Si6XH5 (X= H, F, Cl, Br, COOH, NO2, NH2, CH3 and tBu). Journal of Physical & Theoretical Chemistry, 14 (2018) 283-293.
 M. Nabati, Prediction of the Structural and Spectral Properties and Reactivity of the Silicon Analogs of Cyclobutadiene C4-nSinH4 (n=0-4) by Density Functional Theory Computations. Chemical Methodologies, 1 (2017) 121-135.
 M. Nabati, Prediction of the structural and spectral properties for L, L-ethylenedicysteine diethylester (EC) and its complex with Technetium-99m radionuclide. Journal of Physical & Theoretical Chemistry, 14 (2017) 49-61.
 M. Nabati and H. Sabahnoo, Spectroscopic (FT-IR and UV-Vis), electronic and docking studies on the red clover isoflavone irilone as a progesterone receptor (PR) effect supporter in endometrial and ovarian cancer cell lines. Journal of Medicinal and Chemical Sciences, 2 (2019) 118-125.
 M. Nabati, Modeling and interactions analysis of the novel antagonist agent flibanserin with 5-hydroxytryptamine 2A (5-HT2A) serotonin receptor as a HSDD treatment in premenopausal women. Iranian Chemical Communication, 7 (2019) 324-334.
 M. Nabati, H. Sabahnoo, E. Lohrasbi and M. Mazidi, Structural Properties Study and Spectroscopic (FT-IR and UV-Vis) Profiling of the Novel Antagonist LY2157299 as a Transforming Growth Factor-β (TGF-β) Receptor I Kinase Inhibitor by Quantum-mechanical (QM) and Molecular Docking Techniques. Chemical Methodologies, 3 (2019) 377-391.
 M. Nabati, Insight into the Stability, Reactivity, Structural and Spectral Properties of the Anti, Syn-endo and Syn-exo Isomers of Bis(N-ethoxy-N-ethyl-dithiocarbamato)Nitrido Technetium-99m [99mTc-N(NOEt)2] Radiopharmaceutical. Chemical Methodologies, 2 (2018) 223-238.
 M. Nabati, Structural and spectral (IR, UV-Vis, CD and DOS) properties of active substance d,l-HMPAO and its complex with technetium-99m radionuclide 99mTc-exametazime. Iranian Journal of Organic Chemistry, 10 (2018) 2457-2465.
 M. Nabati, Insight into the structural and spectral (IR and UV-Vis) properties of the salts of alkali (Li, Na and K) and alkaline earth (Be, Mg and Ca) metals with pertechnetate oxoanion (99mTcO4-) as the convenient water-soluble sources of the radioactive element technetium. Asian Journal of Green Chemistry, 3 (2019) 258-270.
 A. Kumer, N. Sarker, S. Paul and A. Zannat, The Theoretical Prediction of Thermophysical properties, HOMO, LUMO, QSAR and Biological Indics of Cannabinoids (CBD) and Tetrahhdrocannabinol (THC) by Computational Chemistry. Advanced Journal of Chemistry, Section A: Theoretical, Engineering and Applied Chemistry, 2 (2019) 190-202.
 M. Rahimi, S. Jamehbozorgi, H. Chermette, R. Ghiasi and M. Poor Kalhor, Computational study of substituent effect on the electronic properties of ferrocylidene acetophenones complexes. Iranian Chemical Communication, 7 (2019) 472-479.
 M. Nabati and M. Mahkam, pH-sensitive nano carriers for oral-curcumin delivery. Iran. J. Org. Chem, 5 (2013) 1157-1161.
 K.K. Alisher, T.S. Khamza and Y.S. Ikbol, Quantum-chemical study of geometric and energy characteristics of some bases of shiff gossipol. Progress in Chemical and Biochemical Research, 2 (2019) 1-5.
 F. Abdollahi, A. Taheri and M. Shahmari, Application of selective solid-phase extraction using a new core-shell-shell magnetic ion-imprinted polymer for the analysis of ultra-trace mercury in serum of gallstone patients. Separation Science and Technology, (2019) 1-14.